Objective
ENCCA aims to establish a durable, European Virtual Institute clinical and translational research in childhood and adolescent cancers that will define and implement an integrated research strategy and will facilitate the necessary investigator-driven clinical trials to introduce the new generation of biologically targeted drugs into standard of care for children and adolescents with cancer. This will lead to more efficacious and less toxic therapies that will maximise the quality of life of the increasing number of survivors of cancer at a young age in Europe and allow them to assume their proper place in society. This biologically-driven research agenda will improve training of the clinical investigators and translational scientists of the future to spread excellence, increase capacity to participate in research and monitor outcomes across Europe. Patients and their families will be full partners and will be better informed about the need for and processes of clinical research. They will be in a better situation to care from their long term health risks for children. Drug development will be accelerated in partnership with industry through improved access to young patients with cancer, to academic expertise in care, clinical and biological research. All of this will be achieved with respect for the highest ethical and patient safety standards. ENCCA will bring all stakeholders to the table in a timely and efficacious manner. It will address the needs of all the current multinational clinical trial groups for the benefit of children with cancer. It will provide them with common tools and approaches to solve the bottlenecks in testing new therapeutic strategies for those rare diseases in a vulnerable age group and in running a competitive clinical research agenda. Ongoing efforts to coordinate EU and US clinical research will be reinforced. ENCCA will be led by the most active EU institutes in the field (31), recognised as being at the forefront of excellence.
Field of science
- /medical and health sciences/clinical medicine/cancer
Call for proposal
FP7-HEALTH-2010-single-stage
See other projects for this call
Funding Scheme
NoE - Network of Excellence
Coordinator
1090 Wien
Austria
Participants (33)
1200 Bruxelles
WC1E 6BT London
24118 Kiel
94805 Villejuif
20123 Milano
Participation ended
45147 Essen
20126 Milano
3015 GD Rotterdam
46026 Valencia
80210 Gdansk
B15 2TT Birmingham
LS9 7TF Leeds
16147 Genova
75231 Paris
70013 Irakleio
1210 Wien
40033 Casalecchio Di Reno Bo
1010 Vienna
1105AZ Amsterdam
69373 Lyon
69372 Lyon Cedex 08
2333 ZA Leiden
17177 Stockholm
9000 Gent
10117 Berlin
75000 Paris
70173 Stuttgart
1000 Bruxelles
1090 Wien
35122 Padova
48149 Muenster
SO17 1BJ Southampton
LS2 9JT Leeds
